Suscribirse

SNORING, OBSTRUCTIVE SLEEP APNEA, AND SURGERY - 07/09/11

Doi : 10.1016/S0025-7125(05)70089-4 
Steven W. Barthel, MD *, Marshall Strome, MD, MS, FACS *

Resumen

Snoring is a common condition affecting up to 60% of the adult population with significant physical and social consequences.95 Nearly all patients with obstructive sleep apnea (OSA) snore, and a significant number of patients who snore may suffer from OSA. OSA has been recognized as a prevalent and important cause of sleep disturbance with dire physical and social consequences if untreated. OSA is characterized by episodes of apnea and hypopnea during sleep. Apnea is defined as cessation of air flow for 10 or more seconds. When respiratory effort remains, the apnea is termed obstructive. Hypopnea refers to a greater than 50% reduction in air flow.20 OSA syndrome is defined by episodes of obstructive apneas and hypopneas accompanied by daytime somnolence, altered cardiovascular function, or both, resulting from the respiratory dysfunction.27 Minimal criteria for the number of apneas or hypopneas per hour have varied among authors. Currently, more than five apneas or hypopneas per hour is used, most commonly, as minimal criteria for OSA syndrome and is reported as apnea-hypopnea index (AHI). OSA is considered mild if the AHI is 6 to 20, moderate if the AHI is 21 to 50, and severe if the AHI is more than 50.

The prevalence of OSA syndrome in the middle-aged work force is approximately 4% of men and 2% of women.103 In the elderly, estimates range from 28% to 67% in men and 20% to 54% in women.2, 24, 46, 60, 72 The prevalence of OSA syndrome in commercial truck drivers has been reported to be as high as 46%.87 In 1993, the National Commission on Sleep Disorders Research estimated that 18 million Americans suffer from OSA syndrome.54 In addition to being prevalent, OSA syndrome is now considered to be a major public health concern.61 In patients with an apnea index greater that 20, the cumulative 8-year mortality of untreated OSA was 37% as compared to 4% for those with an index at or below 20.31 This increased mortality is likely attributable to increased cardiovascular morbidity, including myocardial infarction, dysrhythmias, and stroke,55, 56 and traffic accidents.17, 88 Additionally, OSA has been identified as an independent contributor to the development of hypertension.7, 34 OSA may be responsible for 38,000 cardiovascular deaths per year, and the cost of OSA is approximately $42 million annually from hospitalization alone.54 Especially concerning are that as many as 95% of OSA patients may be undiagnosed.54

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Marshall Strome, MD, MS, FACS, Otolaryngology Desk A71, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195-0001


© 1999  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 83 - N° 1

P. 85-96 - janvier 1999 Regresar al número
Artículo precedente Artículo precedente
  • SORE THROAT, TONSILLITIS, AND ADENOIDITIS
  • Mark A. Richardson
| Artículo siguiente Artículo siguiente
  • SWALLOWING DISORDERS
  • Edgar Domenech, James Kelly

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.